David H. Mack's most recent trade in PMV Pharmaceuticals Inc was a trade of 220,643 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals Inc | David H. Mack | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2025 | 220,643 | 0 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | David H. Mack | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.37 per share. | 27 Oct 2025 | 220,643 | 451,109 | - | 1.4 | 302,281 | Common Stock |